FKB327, an adalimumab biosimilar, versus the reference product: results of a randomized, Phase III, double-blind study, and its open-label extension
Genovese, Mark C, Glover, Josephine, Greenwald, Maria, Porawska, Wieslawa, El Khouri, Elias Chalouhi, Dokoupilova, Eva, Vargas, Juan Ignacio, Stanislavchuk, Mykola, Kellner, Herbert, Baranova, Elena, Matsunaga, Nobuhito, Alten, Rieke
Published in Arthritis research & therapy (12.12.2019)
Published in Arthritis research & therapy (12.12.2019)
Get full text
Journal Article
Long-term efficacy and safety in patients with rheumatoid arthritis continuing on SB4 or switching from reference etanercept to SB4
Emery, Paul, Vencovský, Jiří, Sylwestrzak, Anna, Leszczyński, Piotr, Porawska, Wieslawa, Stasiuk, Barbara, Hilt, Joanna, Mosterova, Zdenka, Cheong, Soo Yeon, Ghil, Jeehoon
Published in Annals of the rheumatic diseases (01.12.2017)
Published in Annals of the rheumatic diseases (01.12.2017)
Get full text
Journal Article
A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapy
Emery, Paul, Vencovský, Jiří, Sylwestrzak, Anna, Leszczyński, Piotr, Porawska, Wieslawa, Baranauskaite, Asta, Tseluyko, Vira, Zhdan, Vyacheslav M, Stasiuk, Barbara, Milasiene, Roma, Barrera Rodriguez, Aaron Alejandro, Cheong, Soo Yeon, Ghil, Jeehoon
Published in Annals of the rheumatic diseases (01.01.2017)
Published in Annals of the rheumatic diseases (01.01.2017)
Get full text
Journal Article
Safety, immunogenicity and efficacy after switching from reference infliximab to biosimilar SB2 compared with continuing reference infliximab and SB2 in patients with rheumatoid arthritis: results of a randomised, double-blind, phase III transition study
Smolen, Josef S, Choe, Jung-Yoon, Prodanovic, Nenad, Niebrzydowski, Jaroslaw, Staykov, Ivan, Dokoupilova, Eva, Baranauskaite, Asta, Yatsyshyn, Roman, Mekic, Mevludin, Porawska, Wieslawa, Ciferska, Hana, Jedrychowicz-Rosiak, Krystyna, Zielinska, Agnieszka, Lee, Younju, Rho, Young Hee
Published in Annals of the rheumatic diseases (01.02.2018)
Published in Annals of the rheumatic diseases (01.02.2018)
Get full text
Journal Article
52-week results of the phase 3 randomized study comparing SB4 with reference etanercept in patients with active rheumatoid arthritis
Emery, Paul, Vencovský, Jirí, Sylwestrzak, Anna, Leszczynski, Piotr, Porawska, Wieslawa, Baranauskaite, Asta, Tseluyko, Vira, Zhdan, Vyacheslav M, Stasiuk, Barbara, Milasiene, Roma, Barrera Rodriguez, Aaron Alejandro, Cheong, Soo Yeon, Ghil, Jeehoon
Published in Rheumatology (Oxford, England) (01.12.2017)
Published in Rheumatology (Oxford, England) (01.12.2017)
Get full text
Journal Article